Long-term clinical outcomes and prognostic factors of upfront surgery as a first-line therapy in biopsy-proven clinical N2 non-small cell lung cancer

BACKGROUND: Multimodality therapy offers the best opportunity to improve pathological N2 non-small cell lung cancer (NSCLC) prognosis. This paper aimed to evaluate the long-term clinical outcomes and the prognostic factors of upfront surgery as first-line therapy in biopsy-proven clinical N2. METHOD...

Descripción completa

Detalles Bibliográficos
Autores principales: Bertolaccini, Luca, Prisciandaro, Elena, Guarize, Juliana, Girelli, Lara, Sedda, Giulia, Filippi, Niccolò, de Marinis, Filippo, Spaggiari, Lorenzo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9366141/
https://www.ncbi.nlm.nih.gov/pubmed/35965495
http://dx.doi.org/10.3389/fonc.2022.933278

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9366141/
https://www.ncbi.nlm.nih.gov/pubmed/35965495
http://dx.doi.org/10.3389/fonc.2022.933278

Ejemplares similares